胶质瘤患者强化运动项目(ActiNO)的概念开发:临床经验总结
该研究总结了自2011年起对胶质瘤患者实施ActiNO运动项目的经验,项目包括每周两次、每次一小时的个体化训练(功率自行车和全身抗阻训练)。截至2019年12月共纳入45例患者,中位年龄49岁。在1828次训练中发生2次轻微癫痫事件,该监督下次极量运动项目可行且安全。
要点
- ActiNO项目为每周两次、每次一小时的个体化训练,包括功率自行车和全身抗阻训练。
- 45例胶质瘤患者中,最常见为胶质母细胞瘤(58%),其次为弥漫性低级别星形细胞瘤(29%)。
- 共1828次训练中发生2次轻微癫痫事件(1次言语中断,1次局灶性发作),项目可行且安全。
核心结论
- 该监督下的次极量运动项目在无论WHO分级的胶质瘤患者中可行且安全。
研究设计与样本
- 研究邀请胶质瘤患者参与ActiNO项目,自2011年起由运动科学家根据患者症状个体化制定每周两次、每次一小时的训练。
- 截至2019年12月,共45例胶质瘤患者纳入分析,中位年龄49岁(IQR 42-59)。
主要发现
- 患者中最常见为胶质母细胞瘤(58%),其次为弥漫性低级别星形细胞瘤(29%)。
- 共进行1828次训练,发生2次轻微癫痫事件(1次言语中断,1次局灶性发作)。
- 体能评估中所有患者均达到年龄校正最大心率的至少75%,峰值功平均172 W(95% CI 156-187)。
- 参与项目的胶质母细胞瘤患者中位生存期为24.1个月(95% CI 8.6-39.5)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Exercise proved to reduce cancer-related symptoms and prolong survival in some cancer types. However, brain tumor patients are often advised against strenuous exercise. Here, we summarize our experience with a submaximal exercise program for glioma patients: ActiNO (Active in Neuro-Oncology). METHODS: Glioma patients were invited to participate in the program. Since 2011, a sports scientist individualized two one-hour sessions per week adapted to the patients' symptoms. One session consisted of bicycle ergometry (average workload: 75% of maximum heart rate), the other of whole-body resistance training. Both sessions were further complimented by coordinative elements. Cardiorespiratory fitness was assessed using the "Physical Work Capacity" procedure. Patients were followed up regularly to assess adherence to the program and disease activity. RESULTS: Until December 2019, 45 glioma patients, median-aged 49 years (IQR 42-59), were included in the analysis. Most patients suffered from glioblastoma (58%), followed by diffuse lower-grade astrocytoma (29%). In overall 1828 training sessions, two minor epileptic events occurred (1 speech arrest; 1 focal seizure). During fitness assessment, all patients achieved at least 75% of their age-adjusted maximum heart rate. Peak workload averaged 172 W (95% CI 156-187). Median survival of participating glioblastoma patients was 24.1 months (95% CI 8.6-39.5). CONCLUSION: This supervised training program with submaximal exertion was feasible and safe in glioma regardless of WHO grading. Based on these experiences, we initiated a prospective multicenter study to objectify improvements in physical performance and quality of life in patients with glioblastoma.
引用
- Jost J, Müther M, Brandt R, et al. Conceptual development of an intensive exercise program for glioma patients (ActiNO): summary of clinical experience. J Neurooncol. 2023. PMID: 37306887. doi:10.1007/s11060-023-04354-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。